July 28, 2017 4:00 PM ET

Biotechnology

Company Overview of Warp Drive Bio, LLC

Company Overview

Warp Drive Bio, LLC develops genomic technology to discover drugs of natural origin. The company also engages in development of drugs. Warp Drive Bio, LLC was incorporated in 2010 and is based in Cambridge, Massachusetts.

215 First Street

Cambridge, MA 02142

United States

Founded in 2010

Phone:

617-492-0913

Fax:

617-492-0919

Key Executives for Warp Drive Bio, LLC

Chief Executive Officer and President
Age: 53
Founder and Executive Chairman
Age: 45
Co-Founder, Chairman of the Scientific Advisory Board and Director
Age: 58
Chief Operating Officer
Chief Scientific Officer
Compensation as of Fiscal Year 2017.

Warp Drive Bio, LLC Key Developments

Warp Drive Bio, LLC Presents at The 24th Annual Future Leaders in the Biotech Industry Conference, Apr-07-2017 08:30 AM

Warp Drive Bio, LLC Presents at The 24th Annual Future Leaders in the Biotech Industry Conference, Apr-07-2017 08:30 AM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States.

Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors

Warp Drive Bio announced that Steven H. Holtzman will join the company’s board of directors. Mr. Holtzman brings to Warp Drive Bio more than 30 years of leadership experience in the biotechnology industry. Mr. Holtzman comes to Warp Drive Bio as the current chief executive officer for Decibel Therapeutics. Prior to Decibel, he served as the executive vice president, corporate development at Biogen Inc., where he lead the leadership team through six new drug approvals. Mr. Holtzman also held positions at Infinity Pharmaceuticals Inc., where he served as founder, chief executive officer and chair of the board of directors. Previously, he was the chief business officer of Millennium Pharmaceuticals, now Takeda Oncology and prior to that a founder, board member and executive vice president of DNX Corporation. Mr. Holtzman is a member of the boards of directors for PMV Pharma, Visterra, Humatics, The Sync Project and Molecular Partners. He is also currently a trustee of the Berklee College of Music and has previously served on the board of trustees for the Hastings Center for Ethics and the Life Sciences.

Warp Drive Bio Appoints Rachel K. King to Board of Directors

Warp Drive Bio announced that Rachel K. King will join the company’s board of directors. Ms. King brings to Warp Drive Bio over 25 years of biotechnology leadership experience. Ms. King has spent the last 13 years serving as chief executive officer for GlycoMimetics Inc. Prior to that, she spent two years at New Enterprise Associates where she served as an entrepreneur-in-residence.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Warp Drive Bio, LLC, please visit www.warpdrivebio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.